Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Study ID: NCT07216703
Start Date: 2025-11-18
End Date: 2031-10-29
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1023

Intervention / Treatment

Pembrolizumab

Sacituzumab Tirumotecan

bevacizumab

Paclitaxel

Cisplatin

Carboplatin

Rescue Medications

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients

Study ID: NCT06824818
Start Date: 2026-06
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

155

Intervention / Treatment

LHRH Agonist Therapy Discontinuation

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury

Study ID: NCT07109804
Start Date: 2025-11-30
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

6

Intervention / Treatment

Deep Brain Stimulation (DBS)

Deep Brain Stimulation (DBS) Device Implant Procedure

Training Sessions

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment

Study ID: NCT06780917
Start Date: 2026-01
End Date: 2029-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

Centre for Addiction and Mental Health

Source: clinicaltrials.gov

Share:
Add to list

Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis

Study ID: NCT07203391
Start Date: 2025-12-01
End Date: 2029-12-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

8

Intervention / Treatment

roginolisib

Sponsor

St Vincent's Hospital, Sydney

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Study ID: NCT07222488
Start Date: 2025-12-01
End Date: 2029-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

MK-3120

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Adolescent Stress and Substance Intervention Subsequent to Trauma

Study ID: NCT07197476
Start Date: 2026-01
End Date: 2027-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

62

Intervention / Treatment

ASSIST Video Intervention

Sponsor

Rhode Island Hospital

Source: clinicaltrials.gov

Share:
Add to list

Prescriptive Infusion Algorithm (PIA)

Study ID: NCT07215403
Start Date: 2026-05-01
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

Prescriptive Infusion Algorithm

AB-1005

Sponsor

AskBio Inc

Source: clinicaltrials.gov

Share:
Add to list

Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery

Study ID: NCT06521086
Start Date: 2025-12-01
End Date: 2027-01-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Nutrition Supplements - Fresubin KCAL Drinks

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

Study ID: NCT06924827
Start Date: 2026-02-02
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

25

Intervention / Treatment

Epidiolex 100 mg/mL Oral Solution

Sponsor

Elizabeth Donner

Source: clinicaltrials.gov

Share:
Add to list